Biolife Solutions (BLFS) EV to EBITDA (2010 - 2026)

Biolife Solutions (BLFS) has reported EV to EBITDA for 17 consecutive years, with 765.46 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 1400.94% year-over-year to 765.46 in Q2 2026; TTM through Jun 2026 was 435.5, a 857.36% increase from a year earlier, with the FY2025 full-year figure at 64.84, up 74.01% from the prior year.
• EV to EBITDA was 765.46 for Q2 2026 at Biolife Solutions, down from 31503.35 in the prior quarter.
• Over five years, EV to EBITDA peaked at 31503.35 in Q1 2026 and troughed at 12861.26 in Q3 2025.
• A 5-year average of 900.57 and a median of 62.01 in 2023 frame the typical range for EV to EBITDA.
• The widest YoY moves for EV to EBITDA: up 5137.32% in 2024, down 7270.16% in 2024.
• Over 5 years, EV to EBITDA stood at 7.93 in 2022, then soared by 395.93% to 39.35 in 2023, then soared by 5137.32% to 2060.82 in 2024, then slumped by 61.22% to 799.2 in 2025, then dropped by 4.22% to 765.46 in 2026.
• The last three EV to EBITDA figures came in at 765.46 (Q2 2026), 31503.35 (Q1 2026), and 799.2 (Q4 2025), per Business Quant data.